ADC Therapeutics SA (ADCT)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 4.5000 |
| Open | 4.4700 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 800 |
| Day's range | 4.3500 - 4.5800 |
| 52-week range | 0.3600 - 6.0400 |
| Volume | |
| Avg. volume | 620,045 |
| Market cap | 365.21M |
| Beta (5Y monthly) | 1.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
US$10.00 - That's What Analysts Think ADC Therapeutics SA (NYSE:ADCT) Is Worth After These Results
There's been a notable change in appetite for ADC Therapeutics SA ( NYSE:ADCT ) shares in the week since its annual...
- Insider Monkey
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript
ADC Therapeutics SA (NYSE:ADCT) Q4 2023 Earnings Call Transcript March 13, 2024 ADC Therapeutics SA misses on earnings expectations. Reported EPS is $-1.03 EPS, expectations were $-0.47. ADCT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the ADC Therapeutics […]
- Thomson Reuters StreetEvents
Q4 2023 ADC Therapeutics SA Earnings Call
Q4 2023 ADC Therapeutics SA Earnings Call
© 2024 Yahoo. All rights reserved.